Literature DB >> 26355255

Hypervolemia and Sleep Apnea in Kidney Disease.

Owen D Lyons1, T Douglas Bradley2, Christopher T Chan3.   

Abstract

In end-stage renal disease (ESRD) and heart failure, conditions characterized by fluid overload, both obstructive sleep apnea (OSA) and central sleep apnea (CSA) are highly prevalent. This observation suggests that fluid overload may be a unifying mechanism in the pathogenesis of both OSA and CSA in these conditions. An overnight rostral fluid shift from the legs to the neck and lungs has been shown to contribute to the pathogenesis of OSA and CSA, respectively, in various different patient populations. This article reviews the evidence that supports a role for fluid overload and overnight fluid shift in the pathogenesis of sleep apnea in ESRD. The diagnosis, epidemiology, and clinical features of sleep apnea in patients with ESRD also are considered.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  End-stage renal disease; central sleep apnea; fluid overload; fluid shift; obstructive sleep apnea

Mesh:

Year:  2015        PMID: 26355255     DOI: 10.1016/j.semnephrol.2015.06.008

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  6 in total

Review 1.  Effect of Antihypertensive Medications on the Severity of Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis.

Authors:  Kiran Khurshid; Jonathan Yabes; Patricia M Weiss; Sushma Dharia; Lee Brown; Mark Unruh; Manisha Jhamb
Journal:  J Clin Sleep Med       Date:  2016-08-15       Impact factor: 4.062

Review 2.  The neural basis of homeostatic and anticipatory thirst.

Authors:  Claire Gizowski; Charles W Bourque
Journal:  Nat Rev Nephrol       Date:  2017-11-13       Impact factor: 28.314

3.  Residual Renal Function and Obstructive Sleep Apnea in Peritoneal Dialysis: A Pilot Study.

Authors:  Aviya Lanis; Eric Kerns; Susie L Hu; Margaret H Bublitz; Patricia Risica; Susan Martin; Jeffrey Parker; Richard Millman; Lance D Dworkin; Ghada Bourjeily
Journal:  Lung       Date:  2018-05-26       Impact factor: 2.584

Review 4.  Exercise intolerance in kidney diseases: physiological contributors and therapeutic strategies.

Authors:  Danielle L Kirkman; Natalie Bohmke; Salvatore Carbone; Ryan S Garten; Paula Rodriguez-Miguelez; Robert L Franco; Jason M Kidd; Antonio Abbate
Journal:  Am J Physiol Renal Physiol       Date:  2020-12-07

Review 5.  Fluid Redistribution in Sleep Apnea: Therapeutic Implications in Edematous States.

Authors:  Bruno Caldin da Silva; Takatoshi Kasai; Fernando Morgadinho Coelho; Roberto Zatz; Rosilene M Elias
Journal:  Front Med (Lausanne)       Date:  2018-01-22

6.  Telmisartan attenuates kidney apoptosis and autophagy-related protein expression levels in an intermittent hypoxia mouse model.

Authors:  Xiao-Bin Zhang; Jing-Huang Cai; Yu-Yun Yang; Yi-Ming Zeng; Hui-Qing Zeng; Miao Wang; Xiao Cheng; Xiongbiao Luo; Henry Chidozie Ewurum
Journal:  Sleep Breath       Date:  2018-09-15       Impact factor: 2.816

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.